Skip to content

Clinical Trial on the Treatment of Atopic Dermatitis with Heart Fire and Spleen Deficiency Syndrome by Modified Allergy Decoction

Clinical Trial on the Treatment of Atopic Dermatitis with Heart Fire and Spleen Deficiency Syndrome by Modified Allergy Decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098859
Enrollment
Unknown
Registered
2025-03-14
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Treatment group:Oral Jiawei Allergy Decoction Granules Combined with External Vitamin E Milk Treatment: Jiawei Allergy Decoction: 10g Peony Peel, 3g Lotus Seed Heart, 10g Atractylodes macrocephala, 15
For external use in the experiment, vitamin E milk (JingG Makeup Website Preparation Zi 2022002134) should be evenly applied to the affected area in a dosage of 1 index finger tip ˜ 2 palm area skin l
Control group:Oral placebo granules combined with vitamin E emulsion for external use: placebo, provided by Jiangyin Tianjiang Pharmaceutical Co., Ltd., is formulated by dextrin, essence, edible pigme
Experimental external use of vitamin E milk (JingG Makeup Net Preparation Zi 2022002134), with the same dosage and usage as the treatment group. Follow up every 2 weeks for scoring and recording, with

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.18<= Age<= 60 years old, regardless of gender; 2. Meets the diagnostic criteria of Western medicine for atopic dermatitis; 3.Conforming to the traditional Chinese medicine syndrome differentiation standards for heart fire and spleen deficiency syndrome; 4.Not taking antihistamines or topical hormone ointments in the past week; 5.SCORAD <= 50 points, VAS score <= 7 points; 6.The patient voluntarily signs informed consent.

Exclusion criteria

Exclusion criteria: 1.Accompanied with severe hypertension, diabetes and other primary diseases or combined with other skin diseases; 2. Individuals who are allergic to experimental drug ingredients; 3.Pregnancy, lactation, or recent pregnancy planning; 4.Individuals who have received medication such as hormones and antihistamines within one week; 5.Participating in other clinical researchers; 6.The researcher believes that it is not suitable to participate in this experiment. Those who meet any of the above conditions will be excluded.

Design outcomes

Primary

MeasureTime frame
SCORAD score;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score;

Countries

China

Contacts

Public ContactNie Jing

Beijing University of Chinese Medicine Third Affiliated Hospital

805051012@qq.com+86 138 1100 2041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026